Oncology Archives - Insights

Phenotype-specific approach transcends traditional testing for autoimmune neurological conditions

Chris Bahnsen — Mon, 08 Jun 2026 13:00:00 +0000

Autoimmune neurology testing has evolved beyond limited paraneoplastic evaluations to phenotype-specific panels that identify clinically relevant antibodies. This phenotype-specific approach significantly improves diagnostic accuracy, reduces false positives, and helps guide faster, more personalized treatment for complex neurological diseases.

The post Phenotype-specific approach transcends traditional testing for autoimmune neurological conditions appeared first on Insights.

Genome-Wide Methylation Array Analysis

Robin Huiras-Carlson — Tue, 02 Jun 2026 13:00:00 +0000

Learn more about Mayo Clinic Laboratories’ new genome-wide methylation array from the Mayo Clinic neuro-oncology testing experts who worked alongside the National Institutes of Health to develop the innovative, first-in-class assay.

The post Genome-Wide Methylation Array Analysis appeared first on Insights.

New assay can detect fusions in 1,445 genes across wide range of tumors

Chris Bahnsen — Mon, 20 Apr 2026 13:00:00 +0000

New wtRNA-seq test detects fusions in 1,445 genes with high accuracy, improving cancer diagnosis, treatment decisions, and clinical trial eligibility.

The post New assay can detect fusions in 1,445 genes across wide range of tumors appeared first on Insights.

Rare kidney disease diagnostic advances recognized for clinical impact

Jessie Fenske — Thu, 02 Apr 2026 13:00:00 +0000

Research improves the diagnosis of rare Birt-Hogg-Dubé syndrome, closing genetic testing gaps, guiding care, and earning recognition as a top paper.

The post Rare kidney disease diagnostic advances recognized for clinical impact appeared first on Insights.

Selecting Pathology Specimens for Solid Tumor Next-Generation Sequencing

MCL Education — Mon, 23 Mar 2026 20:50:06 +0000

This microlearning provides a practical, structured approach to evaluating specimens for molecular testing using real examples and criteria drawn from laboratory practice to support confident, consistent decision-making.

The post Selecting Pathology Specimens for Solid Tumor Next-Generation Sequencing appeared first on Insights.

Whole transcriptome RNA sequencing

Robin Huiras-Carlson — Tue, 03 Feb 2026 14:00:00 +0000

Learn more about how Mayo Clinic Laboratories approach to whole transcriptome RNA sequencing provides the most comprehensive detection of gene fusions in solid tumors through use of next-generation sequencing to identify fusions in 1,445 genes.

The post Whole transcriptome RNA sequencing appeared first on Insights.

LiquidHALLMARK®: Advancing liquid biopsy testing with DNA and RNA

jgilligan1 — Wed, 19 Nov 2025 14:00:00 +0000

LiquidHALLMARK combines DNA and RNA for more accurate cancer profiling, helping patients access lifesaving therapies.

The post LiquidHALLMARK®: Advancing liquid biopsy testing with DNA and RNA appeared first on Insights.

Upcoming webinar: Revolutionizing cancer diagnosis with LiquidHALLMARK®

MCL Education — Thu, 04 Sep 2025 13:00:00 +0000

Join us for a webinar exploring how LiquidHALLMARK®, a cutting-edge liquid biopsy test, is transforming cancer care.

The post Upcoming webinar: Revolutionizing cancer diagnosis with LiquidHALLMARK® appeared first on Insights.

Expanded Assay Better Identifies Hereditary Pancreatitis: Linda Hasadsri, M.D., Ph.D., and Huong Cabral, M.S., CGC

Barbara J. Toman — Tue, 15 Jul 2025 13:00:00 +0000

Linda Hasadsri, M.D., Ph.D., and Huong Cabral, M.S., CGC, explain how Mayo Clinic Laboratories' expanded test panel captures rarer as well as more common genetic causes of hereditary pancreatitis. That information is key to managing patients' enhanced risk for pancreatic cancer.

The post Expanded Assay Better Identifies Hereditary Pancreatitis: Linda Hasadsri, M.D., Ph.D., and Huong Cabral, M.S., CGC appeared first on Insights.

Precision in the pancreas: A new genetic test transforms hereditary pancreatitis diagnosis and care

jgilligan1 — Tue, 24 Jun 2025 13:00:00 +0000

Mayo Clinic Laboratories’ newly expanded Hereditary Pancreatitis Gene Panel is transforming how clinicians diagnose and manage a complex, often elusive disease. Developed through close collaboration between lab scientists, genetic counselors, and clinicians, the test uses a whole exome sequencing backbone to analyze nine carefully selected genes with strong clinical relevance. This focused approach avoids ambiguous results while empowering early diagnosis, cancer risk assessment, and family testing. Built on a whole exome backbone with reflex capabilities, the panel represents a major step forward in precision medicine — offering clarity for patients and providers, and a platform for future genomic innovation.

The post Precision in the pancreas: A new genetic test transforms hereditary pancreatitis diagnosis and care appeared first on Insights.